IRIS

Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group

LOCATELLI, FRANCO;
2015-01-01
2015
HAEMATOLOGICA
WOS:000351278500004
2-s2.0-84920178694
Inglese
100
1
e10
e13
25304610
Acute lymphoblastic leukemia; Children and adolescents; SIL/TAL1; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Child; Child, Preschool; Cohort Studies; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Immunophenotyping; Infant; Intracellular Signaling Peptides and Proteins; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Oncogene Proteins, Fusion; Patient Outcome Assessment; Polymerase Chain Reaction; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Proto-Oncogene Proteins; Survival Rate; Hematology
http://www.haematologica.org/content/haematol/100/1/e10.full.pdf
no
19
info:eu-repo/semantics/article
262
D’Angiò, Mariella; Valsecchi, Maria G.; Testi, Anna M.; Conter, Valentino; Nunes, Vittorio; Parasole, Rosanna; Colombini, Antonella; Santoro, Nicola; ...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1112780
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 38
social impact